Headache Characteristics During the Development of Tolerance to Nitrates: Pathophysiological Implications
- 1 June 2000
- journal article
- research article
- Published by SAGE Publications in Cephalalgia
- Vol. 20 (5) , 437-444
Abstract
Recent studies suggest that nitric oxide (NO) plays an important role in nitrate‐induced headache and in spontaneous migraine attacks. Organic nitrates act as prodrugs for NO and headache is a predominant adverse effect of nitrates but often disappears during continuous treatment. Insight into tolerance to headache could lead to insight into vascular headache mechanisms in general. The specific aim of the present study was therefore to characterize the headache and accompanying symptoms during continuous nitrate administration until a state of tolerance to headache had developed. 5‐isosorbide‐mononitrate (5‐ISMN) 30 mg three times daily was administered orally for 7 days in 11 healthy subjects in a double‐blind, randomized placebo controlled cross‐over design. Wash‐out between periods was 14 days or more. Haemodynamic data from the present study were compared to the observed changes of headache over time. Headache during 5‐ISMN was longer lasting and more severe compared to placebo (P < 0.004). In 10 subjects the headache fulfilled the pain sub‐criteria for migraine and in five subjects all diagnostic criteria for migraine without aura were fulfilled. Conversely, 20 min of intravenous infusion of glyceryl trinitrate caused a milder headache and no migraine. The present results therefore suggest that NO may elicit a migraine attack in many healthy subjects if a high enough dose is given for several hours. A close temporal association between the disappearance of headache and the attenuation of the 5‐ISMN induced dilatation of the superficial temporal artery was observed. In contrast, tolerance in the middle cerebral artery already appeared after 24 h, which was earlier than the development of tolerance to headache. If vasodilatation is the cause of headache the results point to extracerebral arteries. However, cytotoxic and pain modulating central nervous system effects of NO, the time courses of which are unknown, may also play a role, involving both intra‐ and extracranial arteries.Keywords
This publication has 27 references indexed in Scilit:
- A nitric oxide donor (nitroglycerin) triggers genuine migraine attacksEuropean Journal of Neurology, 1994
- Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectorisThe American Journal of Cardiology, 1993
- Nitric oxide supersensitivity: a possible molecular mechanism of migraine painNeuroReport, 1993
- Prophylactic nitrate therapy in angina pectoris‐is there an optimal treatment regimen?British Journal of Clinical Pharmacology, 1992
- Dose-dependent headache response and dilatation of limb and extracranial arteries after three doses of 5-isosorbide-mononitrateEuropean Journal of Clinical Pharmacology, 1992
- QUALITY OF LIFE ON ANGINA THERAPY: A RANDOMISED CONTROLLED TRIAL OF TRANSDERMAL GLYCERYL TRINITRATE AGAINST PLACEBOThe Lancet, 1988
- Usefulness of twice-daily isosorbide-5-mononitrate in preventing development of tolerance in angina pectorisThe American Journal of Cardiology, 1987
- Long Term Efficacy of a Controlled-Release Formulation of Isosorbide 5-Mononitrate (Imdur®) in Angina Patients Receiving β-BlockersDrugs, 1987
- Experience of Long Term Treatment and Different Dosage Regimens of Isosorbide 5-MononitrateDrugs, 1987
- THE EFFECTS OF NITROGLYCERIN ON THOSE ENGAGED IN ITS MANUFACTUREJAMA, 1914